Radboudumc is the first hospital in the world to use a new genetic test on a large scale in clinical practice. This test ...

The trial is a phase 1/2 open-label, ascending-dose study of the safety and efficacy of OPGx-LCA5. Recently, the company ...

ADHD is a neurodevelopmental disorder with a high heritability, in which the genetic component consists of thousands of ...

Targeted therapies, guided by molecular testing, offer significant benefits, including fewer side effects and personalization ...

Radboudumc and Maastricht UMC+ are the first hospitals in the world to use a new genetic test to diagnose rare diseases on a ...

The American College of Medical Genetics and Genomics (ACMG) announced today that Melanie Wells, MPH, CAE, Chief Executive ...

By embedding standardized questionnaires and algorithms into routine visits, providers can evaluate risk factors such as age, ...

Positive 3-month pediatric and 18-month adult clinical data from OPGx-LCA5 Phase 1/2 trial support the potential for ...

A recent review published in Genes & Diseases by researchers from the Naval Medical University and the 922nd Hospital of the Joint Service Support Force of the PLA provides a comprehensive overview of ...

Genetic counsellors are equipped to discuss the likelihood of having a genetic condition based on an individual’s personal or ...